about
Galectin-3 and Beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkersPrognostic biomarkers in acute coronary syndromeNuclear transport of galectin-3 and its therapeutic implicationsGalectin-3 in angiogenesis and metastasis.Protein glycosylation in cancers and its potential therapeutic applications in neuroblastomaThe Role of Sialyl-Tn in CancerCirculating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surfaceThe roles of Galectin-3 in autoimmunity and tumor progressionA combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasisGalectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation.Distinct expression of galectin-3 in pheochromocytomas.Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment.Galectin-3 maintains cell motility from the subventricular zone to the olfactory bulb.Molecular basis for MMP9 induction and disruption of epithelial cell-cell contacts by galectin-3.Immunohistochemical study of galectin-3 in mature and immature bull testis and epididymis.Diagnostic utility of galectin-3 in thyroid cancer.The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells.Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells.The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loopExpression of antigen tf and galectin-3 in fibroadenoma.Proteomic comparison of mcf-7 tumoursphere and monolayer culturesThe two endocytic pathways mediated by the carbohydrate recognition domain and regulated by the collagen-like domain of galectin-3 in vascular endothelial cells.Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells.Antitumor mechanisms of amino Acid hydroxyurea derivatives in the metastatic colon cancer model.Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitisThe role of galectin-3 and galectin-3-binding protein in venous thrombosis.Nuclear translocation of immulectin-3 stimulates hemocyte proliferation.Protein glycosylation in cancer.Galectin-3 and cyclin D1 expression in non-small cell lung cancerEpigenetic modifications of caveolae associated proteins in health and disease.Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis.Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia.Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growthGalectins as self/non-self recognition receptors in innate and adaptive immunity: an unresolved paradox.Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell-cell junctions of mammary carcinoma cellsInhibition and detection of galectins.Toward a core nutraceutical program for cancer management.Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.Galectin-3 in apoptosis, a novel therapeutic targetAnalogs of tetrahydroisoquinoline natural products that inhibit cell migration and target galectin-3 outside of its carbohydrate-binding site
P2860
Q21134996-E650E2AD-600D-4D2F-A528-F8B1C4EA272AQ26738521-C476AEF9-359B-4A29-AA41-F924DD2CE031Q26824889-9B3EAB3F-EA1B-4203-BEA8-23CA28AA34C2Q27687444-CC0E3B0A-C51D-4F81-824D-2E6F3D901254Q28069952-DB34898E-9BC9-4A54-B9B9-CBD752004528Q28075448-D4FEF97D-F9C1-4AF5-851F-A1A2AE9BB285Q28255527-6E17578E-7034-44B4-93A7-E662AC533116Q28261890-182E224A-DCEF-4A8B-B68C-6546F2C6C3ABQ28276647-7B9C7DDF-53B8-4707-BF48-6042C083ED3BQ28595005-DEFE1E4F-7FE2-4DF0-A2A5-5DEB3AFDC906Q30319927-A4D4C2EF-8DB7-408A-8CE9-AB8ECB5595A8Q30438758-989681FF-76FE-44D9-BF67-ED93BB072954Q30501653-8D632858-E1B0-4D31-B413-6F26A309F9E4Q30583539-98C9EDD3-E282-424C-A12E-01EF871BF14EQ33612082-68E4CC0A-2B81-45A7-83C9-3DF51A5328AFQ33816239-BD5425F4-C478-493D-BE07-CB0E942B020EQ34000528-47CC2D83-F88F-4383-AF97-EBEC6AD86100Q34179539-97F2635B-4EE9-4460-8C03-7A0333A5DF5FQ34440854-23476CD7-B193-46E6-9024-5F9E26AC3F03Q34522377-9E73C7F7-47F5-4622-901B-F7C7A919BD77Q34534423-62FF89D0-E4C0-4007-A50E-F22D0C097E1DQ34540693-A0003F94-8E06-462A-96AC-C4E59AF0DDCBQ34563122-6EFBF7A9-C341-47D7-80AE-E45A8D1D5122Q35058878-F802FB07-12ED-4D13-BFB2-9576E018E109Q35166192-060230CF-F6CC-4644-823F-90D8B1F7176DQ35171280-85A94052-31AE-4DCB-94AA-24DFC643CC51Q35326039-E7BA470A-A50E-4289-B163-E6C825FD7E91Q35413473-36AD3BA2-80C3-408D-9113-5152329ED43AQ35544158-D328F547-E0A2-412A-83BB-42E5E3099D10Q35674847-73D76882-8B9C-4C39-9D11-5DD2A8B802C6Q35723085-6F78B784-DE92-4094-86C0-F9C8D35D93ECQ35945071-807E28F5-2FAC-4DB7-9021-7997A66B21C6Q36027010-B189B3C6-AB3D-48A8-B7F9-02DD26CF446CQ36093631-81B908AA-A40C-4CEF-A0FD-EEF0BAA4D10EQ36294909-887F9799-2EE1-4123-A20F-645D84856A8FQ36432498-EEEC4A09-7C4D-4C18-B1D5-B180F774510BQ36473648-19AF6090-9C13-4868-A4FE-46E8C498CB78Q36642433-C82FC544-3D09-474C-B256-217BD9AA860DQ36743604-6ECCB3BC-8CA4-4049-AB3E-FDAEF3F9F6DFQ36861463-07672416-D7ED-4B1D-9641-98C2CC42951D
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Galectin-3 and metastasis.
@ast
Galectin-3 and metastasis.
@en
type
label
Galectin-3 and metastasis.
@ast
Galectin-3 and metastasis.
@en
prefLabel
Galectin-3 and metastasis.
@ast
Galectin-3 and metastasis.
@en
P1476
Galectin-3 and metastasis.
@en
P2093
Avraham Raz
Tomoharu Fukumori
P304
P356
10.1023/B:GLYC.0000014084.01324.15
P577
2004-01-01T00:00:00Z
P6179
1045428247